Freestone Grove Partners LP Takes Position in Teleflex Incorporated $TFX

Freestone Grove Partners LP acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 71,554 shares of the medical technology company’s stock, valued at approximately $9,070,000.

Several other large investors also recently bought and sold shares of the business. First Eagle Investment Management LLC raised its holdings in shares of Teleflex by 163.4% in the 4th quarter. First Eagle Investment Management LLC now owns 84,300 shares of the medical technology company’s stock valued at $10,288,000 after purchasing an additional 52,300 shares in the last quarter. Baader Bank Aktiengesellschaft increased its holdings in Teleflex by 32.4% during the fourth quarter. Baader Bank Aktiengesellschaft now owns 43,333 shares of the medical technology company’s stock valued at $5,288,000 after buying an additional 10,600 shares during the period. Diamond Hill Capital Management Inc. increased its holdings in Teleflex by 6.3% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 349,809 shares of the medical technology company’s stock valued at $42,691,000 after buying an additional 20,773 shares during the period. Fifth Third Bancorp raised its stake in Teleflex by 3,204.8% in the first quarter. Fifth Third Bancorp now owns 68,144 shares of the medical technology company’s stock worth $8,151,000 after buying an additional 66,082 shares in the last quarter. Finally, Strs Ohio lifted its holdings in Teleflex by 47.7% during the fourth quarter. Strs Ohio now owns 34,058 shares of the medical technology company’s stock worth $4,156,000 after buying an additional 11,002 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Teleflex Stock Performance

NYSE TFX opened at $139.81 on Friday. The stock has a 50-day simple moving average of $133.86 and a two-hundred day simple moving average of $125.91. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60. The firm has a market capitalization of $5.92 billion, a P/E ratio of -6.00, a PEG ratio of 0.92 and a beta of 0.81. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $145.00.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.48. The firm had revenue of $570.33 million for the quarter, compared to the consensus estimate of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The firm’s quarterly revenue was up 28.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.73 earnings per share. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, equities analysts forecast that Teleflex Incorporated will post 7.26 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, August 14th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Friday, August 14th. Teleflex’s dividend payout ratio (DPR) is -5.84%.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. Raymond James Financial reaffirmed an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Piper Sandler reaffirmed an “overweight” rating and issued a $169.00 price target (up from $160.00) on shares of Teleflex in a report on Friday, August 7th. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and upped their price target for the stock from $135.00 to $155.00 in a research report on Friday, May 8th. Wall Street Zen upgraded Teleflex from a “sell” rating to a “hold” rating in a report on Sunday, August 9th. Finally, Truist Financial lifted their target price on shares of Teleflex from $143.00 to $150.00 and gave the stock a “hold” rating in a research note on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $152.90.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.